Mark Leibowitz, M.D. is an experienced and skilled Investigator with approximately 25 years of research experience. Dr. Leibowitz has participated in an estimated 500 studies from Phase I-IV across a variety of different indications.
As part of his research portfolio, Dr. Leibowitz has conducted highly complex studies in healthy subjects and ... Read More
The Madrigal Phase 2 study manuscript was accepted to The Lancet. Please take a moment to review by clicking on link below. Congratulations to Dr. Frias and the entire NRI team. This is what we do!!!!